Status:
NOT_YET_RECRUITING
Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas
Lead Sponsor:
Assiut University
Conditions:
Bipolar Disorder
Eligibility:
All Genders
15-70 years
Brief Summary
1. Identify randomized controlled trials of tamoxifen (Estrogen Receptor modulator) in in addition to traditional treatment of bipolar disorder and synthesize the results using meta-analysis. 2. Syste...
Detailed Description
Bipolar disorder, formerly known as manic depression, is typified by severe mood fluctuations with emotional highs (mania or hypomania) and lows (depression). Tamoxifen \[TMX\], an oral medication, ha...
Eligibility Criteria
Inclusion
- 1\. Fifty subjects 2.15-70 years of age 3.recently diagnosed as bipolar disorder 4.assigned to receive traditional treatment of bipolar disorder
Exclusion
- Patients who have a concurrent sever illness like cancer ,liver disease
- receiving additional treatment
Key Trial Info
Start Date :
September 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06580535
Start Date
September 5 2024
End Date
December 1 2025
Last Update
August 30 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.